Home > PJ (current issue) > News Feature | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7338 p230
26 February 2005

This article
Reprint   Photocopy

PDF 55K, Acrobat Reader

News feature

NPfIT — more evolution than revolution

It is time for the National Programme for IT to gear up and be ready to support pharmacists with the implementation of the new community pharmacy contract. Hannah Pike (on the staff of The Journal) reports on issues raised at a meeting of the All-Party Pharmacy Group earlier this week


With under five weeks to go before the new community pharmacy contract comes into effect pharmacists will want to know that they have the support of robust IT systems behind them.

It is undisputed that the National Programme for IT has the potential to provide great opportunities for pharmacists in terms of access to patient care records, better communication pathways and benefits expected to result from the electronic transfer of prescriptions (ETP). However, time scales appear to be slipping, implementation looks patchy and communication between the programme, pharmacists and the NHS as a whole leaves a lot to be desired.

The All-Party Pharmacy Group met in Westminster this week, together with representatives from the Pharmaceutical Services Negotiating Committee, the Department of Health, MPs and other members of the pharmacy profession to debate areas of concern.

Over the next few months NPfIT will be testing the national roll out model for ETP through a number of early adopter sites. The PSNC says that it is still in discussions with the Department of Health about time scales for this but expects that it will be progressively rolled out across England between this summer and December 2007. There is now general concern about what interim measures will be put in place to ensure that pharmacies that do not adopt the new systems until later are not disadvantaged.

Lindsay McClure

Lindsay McClure: A gradual evolution

Lindsay McClure, head of information services at the PSNC, explained that different suppliers are currently at different stages of upgrading their systems to support ETP, which has led to concerns about what will happen while there is a mix of ETP-enabled and non-ETP-enabled pharmacies. “It is essential that there is a level playing field for pharmacies during the roll out and that the roll out plan chosen does not negatively impact on patient choice or access to medicines,” she said. However, since arrangements for the national roll out have not yet been finalised, the PSNC is unable to specify how this will be ensured.

Ms McClure said that, although the PSNC supports the Government’s view on competition between pharmacies, it is important that that does not interfere with patient choice. She says that robust systems need to be put in place to prevent abuse of the system and to avoid problems such as prescription direction (PJ, 19 February, p200).

Ms McClure said that the initial benefits for pharmacy from ETP are limited, although the pilots carried out in 2002 demonstrated the potential for ETP to increase the efficiency of dispensing and help manage pharmacy stock levels. However, the Prescription Pricing Authority is likely to benefit financially from automation of systems. “We hope that these savings will be translated into benefits for community pharmacy such as improved accuracy of prescription pricing and quicker payments,” she explained.

An issue that remains to be resolved is how private prescriptions will be handled under the new system since they are prescribed outside the NHS. Neither is it clear how Controlled Drugs will fit into the new plans, since schedule 2 and 3 CDs will not initially be included in ETP arrangements. However, the handling of CDs is likely to change in the near future following recommendations from the Shipman inquiry (PJ, 24 July, p109).

Care records

Access to patient care records is another key area that is yet to be finalised, and a Department of Health consultation on it is expected shortly. Under the new pharmacy contract pharmacists will be obliged to keep records of all NHS supplies made and to record advice given when the information is clinically significant, Ms McClure explained. She pointed out that advanced services such as medicines use reviews will also necessitate record keeping. “Initially this will be paper-based,” she said, “But it would be more effective in the long term if pharmacists could upload summary information about their contact with the patient to the care record so that other health professionals can access this.”

However, when considering enhanced services the situation becomes more complicated, since these are locally commissioned. Pharmacy representatives suggested that a consultation was needed on a national requirement specification for IT for enhanced services in the new contract. For example, what facility will there be for systems to be adapted to meet local need? It is becoming apparent that system suppliers will need to develop their own model specifications to support specific services.

Harry Cayton, director for patients and the public at the Department of Health and chairman of the Care Record Development Board, said that it has set out an NHS care record guarantee (formerly called the information sharing guarantee) outlining the relationship between patients, the NHS and care providers. This outlines how records are created and shared and how they are to be used. He said that the draft was approved by NPfIT last week and he is hoping for approval by ministers shortly.

“ The perception of many is that NPfIT will be an overnight revolution,” said Ms McClure,“In reality it won’t be a revolution, it will be an evolution. New functionality will gradually be added over a number of years and as more and more clinical information is added to the national spine, the programme will deliver an increasing number of benefits for patients, health professionals and the NHS.”

Other issues and suggestions raised at the meeting

Another suggestion raised at the meeting was that patients could hold and be responsible for their own records. This would save money and the onus would be on the patient as to who then had access to this information. Harry Cayton, chairman of the Care Record Development Board, said that although the concept of a patient taking away the information in some form of microchip may be a possibility in the future, for most purposes direct and duplicate access to information will be needed by health care professionals, for example by the ambulance service in an emergency.

Lindsay McClure, head of information services at the PSNC, said that pharmacists should also have access to all areas of the NHS National Electronic Library for Health, instead of being restricted to the public areas of the site. The PSNC also suggests that pharmacists should have NHS e-mail addresses, which, in addition to improving communication of confidential information between health professionals, would also support the NHS branding of community pharmacies. This could also improve patient safety by increasing the speed of communication of drug alerts for example.Ms McClure also pointed out that the “choose and book” programme for booking NHS appointments could be used by patients booking appointments with pharmacists for medication reviews, for example, or could be used by pharmacy staff to signpost customers to other health professionals (an essential service under the new contract).

Back to Top


©The Pharmaceutical Journal